David Saperstein, MD, has dedicated his career to caring for people with retinal problems. In addition to the medical treatment of retinal disease, he has been practicing retinal surgery since 1993. As the chief retinal surgeon at both Grady Hospital in Atlanta and Harborview Hospital in Seattle, he has performed thousands of straightforward and complex retinal surgeries.
His extensive experience working on clinical trials related to retinal disease has enabled him to understand the nuances of both the disease and the various approved and experimental treatments. He takes pride in being able to translate this knowledge into everyday language to help his patients understand why they are having trouble with their vision, what treatments are available, and what the future holds for their individual problem.
After completing his fellowship at Emory University in Atlanta, he was offered a position on the faculty there. I He immediately began to take part in many clinical trials and has been either a primary investigator or on a steering committee for most of the clinical trials studying new treatments for diseases like age-related macular degeneration (both wet and dry), diabetic retinopathy, macular hole, retinal detachment, and inherited retinal disease.
Dr. Saperstein has been asked to write chapters on retinal surgery for textbooks. He has also developed new drugs, surgical and low vision devices for which he holds several US and foreign patents. The drugs he has developed are currently in clinical trials for inherited retinal diseases and aging changes in the retina.
When he is not working, he enjoys spending time with his wife and their twins. He and his family spend their time in or around the water (or snow). They also have a crazy but loveable standard poodle who does on occasion also visit the clinics.